All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make ThemThe Motley Fool • 03/21/20
Trump’s Coronavirus News Conference on Thursday: 3 Key Things That Investors Should KnowThe Motley Fool • 03/20/20
Mylan Ramps Up Production of Hydroxychloroquine as a Potential COVID-19 TreatmentThe Motley Fool • 03/20/20
Mylan's (MYL) CEO Heather Bresch on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/28/20
The FDA and FTC Announce an Effort to Deter Anti-Competitive Practices Among DrugmakersThe Motley Fool • 02/04/20